Accessibility Menu
Covalon Technologies logo

Covalon Technologies(OTC) CVALF

Market Cap$66.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+324%
5 Year+56%
1 Year+54%
1 Month+51%
$2.55
+6.70%
+0.16Today
Covalon Technologies last closing stock price
MetricPriceDate
Last closeUSD 2.392026-09-04
Covalon Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+13%USD 2.122026-08-28
1 month+51.27%USD 1.582026-08-04
3 month+57.63%USD 1.522026-06-05
Year to date+92.74%USD 1.242025-12-31
1 year+54.31%USD 1.552025-09-04
3 year+132.87%USD 1.032023-08-30
5 year+56.19%USD 1.532021-09-02
Since inception+324.25%USD 0.562012-10-24

Covalon Technologies Financials at a Glance

Market Cap

$66.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$34.37M

Net Income (TTM)

CA$4.39M

EPS (TTM)

$0.11

P/E Ratio

20.76

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$2.55

Volume

50,587

Open

$2.46

Previous Close

$2.39

Daily Range

$2.45 - $2.58

52-Week Range

$1.16 - $2.58

Estimated Earnings Date

Dec 10, 2026

CVALF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Covalon Technologies Ltd. is a global medical technology firm specializing in innovative medical solutions. The company focuses on the production, commercialization, and licensing of products designed to improve patient care across various healthcare settings.

Products and Services
  • Wound care dressings for chronic and infected wounds
  • Antimicrobial silicone adhesive products for surgical applications
  • Advanced medical coatings for medical devices
Growth Outlook
  • Recent quarterly revenue reached CAD 8.75 million, a significant increase
  • Trailing twelve months (TTM) revenue shows a growth trend, indicating strong demand
  • Expansion into new markets across the Americas, Europe, and Asia enhances growth potential
Financial Highlights
  • TTM revenue of CAD 30.5 million reflects a solid performance
  • Net income for the latest quarter was CAD 1.1 million, showcasing profitability
  • Current ratio of 7.57 indicates strong liquidity and financial health
Covalon Technologies Ltd. operates within the medical instruments and supplies industry, leveraging three proprietary technological platforms to deliver innovative healthcare solutions. The company's focus on wound care and infection management positions it well in a growing market, driven by an increasing demand for advanced medical technologies. Recent financial performance highlights a robust revenue stream, with the latest quarterly results indicating a significant increase compared to previous periods. The company's ability to maintain a strong current ratio suggests effective management of short-term liabilities, providing a cushion for future growth initiatives. Covalon's strategic expansion into international markets further enhances its growth outlook, as the company seeks to capitalize on emerging opportunities in the healthcare sector. With a commitment to innovation and quality, Covalon Technologies Ltd. presents a compelling case for potential investors interested in the medical technology landscape.
AI Generated • Aug 24, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Brent Ashton

Website

www.covalon.com

Headquarters

Mississauga, ON L4W 5S7, CA

CVALF Financials

Key Financial Metrics (TTM)

Gross Margin

58.09%

Operating Margin

11.49%

Net Income Margin

12.78%

Return on Equity

15.04%

Return on Capital

5.35%

Return on Assets

12.00%

Earnings Yield

4.82%

Dividend Yield

0.00%

Payout Ratio

94.41%

Stock Overview

Market Cap

$66.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.62M

Volume

50.59K

Avg. Volume

8.36K

Financials (TTM)

Gross Profit

CA$19.97M

Operating Income

CA$3.95M

EBITDA

CA$4.94M

Operating Cash Flow

CA$6.96M

Capital Expenditure

-CA$1.20M

Free Cash Flow

CA$5.76M

Cash & ST Invst.

CA$19.40M

Total Debt

CA$1.69M

Covalon Technologies Performance Analysis

Covalon Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30CAD 14,203,326-8.2%
20232023-09-30CAD 19,718,06338.8%
20242024-09-30CAD 22,904,33316.2%
20252025-09-30CAD 23,471,5102.5%
Covalon Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-303.8%
Q12025-12-31-20.8%
Q22026-03-3127.1%
Q32026-06-3014.8%
Covalon Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30CAD -0.29N/A
20232023-09-30CAD -0.13-54.7%
20242024-09-30CAD 0.08N/A
20252025-09-30CAD 0.05-32.8%
Covalon Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30469.6%
Q12025-12-31-65.6%
Q22026-03-31777.8%
Q32026-06-30153.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$10.05M

+20.0%

Gross Profit

CA$6.54M

+68.1%

Gross Margin

65.12%

N/A

Market Cap

$66.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$628.64K

N/A

Employees

105

N/A

Net Income

CA$2.81M

+4255.2%

EBITDA

CA$2.99M

+2073.1%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$19.40M

+7.2%

Total Debt

CA$1.69M

+32.1%

Accounts Receivable

CA$4.58M

-2.9%

Inventory

CA$7.11M

-11.8%

Long Term Debt

CA$1.35M

+84.1%

Short Term Debt

CA$340.02K

-64.1%

Return on Assets

12.00%

N/A

Return on Invested Capital

11.99%

N/A

Free Cash Flow

CA$2.55M

+48.9%

Operating Cash Flow

CA$2.85M

+32.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNMFAmplia Therapeutics Limited
$0.10+5.10%
ACHFFArch Biopartners Inc.
$0.69-7.39%
SEOVFSernova Corp.
$0.09+8.37%
MMIRFMedMira Inc.
$0.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$105.03+0.10%
NOKNokia
$10.75+0.07%
NVDANvidia
$226.13-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.75+0.07%

Questions About CVALF

What is the current price of Covalon Technologies?

Covalon Technologies is trading at $2.55 per share.

What is the 52-week range for Covalon Technologies?

Over the past 52 weeks, Covalon Technologies has traded between $1.16 and $2.58.

How much debt does Covalon Technologies have?

As of the most recent reporting period, Covalon Technologies reported total debt of CA$1.19M.

How much cash does Covalon Technologies have on hand?

Covalon Technologies reported CA$13.66M in cash and cash equivalents in its most recent financial results.

What is Covalon Technologies’s dividend yield?

Covalon Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services